Reditux 500

Reditux 500 is a prescription injectable medicine containing Rituximab 500 mg in 50 mL, shown as a Dr. Reddy’s product. It is a monoclonal antibody medicine used under specialist supervision for certain blood cancers and autoimmune conditions, including Non-Hodgkin’s Lymphoma, Chronic Lymphocytic Leukemia, and Rheumatoid Arthritis, depending on the doctor’s treatment plan. Serious vial, serious supervision, zero room for “bro try karke dekhte hain.” 💉

Composition:

Rituximab – 500 mg / 50 mL

Key Information:

Brand Name: Reditux 500
Strength: 500 mg / 50 mL
Active Ingredient: Rituximab
Dosage Form: Injection / Infusion vial
Medicine Type: Monoclonal antibody / Targeted therapy / Immunotherapy medicine
Manufacturer/Brand Shown: Dr. Reddy’s
Common Use: Treatment of selected blood cancers and autoimmune disorders
Other Prescribed Uses: Non-Hodgkin’s Lymphoma, Chronic Lymphocytic Leukemia, Rheumatoid Arthritis, and other specialist-directed uses
Administration: Intravenous infusion by trained healthcare professionals
Category: Prescription medicine
Pack Size: 1 vial of 50 mL

How It Works:

Reditux 500 contains rituximab, a monoclonal antibody that targets CD20-positive B-cells. These B-cells may be involved in some cancers and autoimmune diseases. By binding to CD20, rituximab helps the immune system remove these targeted cells when used as part of a doctor-supervised treatment plan.

Potential Indications:

• Non-Hodgkin’s Lymphoma, also called NHL
• Chronic Lymphocytic Leukemia, also called CLL
• Rheumatoid Arthritis
• Granulomatosis with Polyangiitis
• Microscopic Polyangiitis
• Other doctor-directed use based on diagnosis and reports

Dosage & Storage:

Use only as directed by a qualified healthcare professional.
Rituximab injection should be administered as an intravenous infusion by trained medical staff.
Do not self-administer this medicine.
Store as per product label instructions. Dr. Reddy’s product information mentions storage at 2°C to 8°C and do not freeze.
Keep out of reach of children.

Important Safety Information:

Rituximab should be used carefully under strict medical supervision, especially in patients with infection risk, hepatitis B history, heart problems, lung problems, low blood counts, or previous allergic/infusion reactions.

Possible side effects may include:

• Fever
• Chills
• Weakness or tiredness
• Nausea
• Headache
• Rash or itching
• Low blood pressure during infusion
• Breathing difficulty
• Increased risk of infections
• Low blood cell counts

Serious risks may include severe infusion reactions, serious skin or mouth reactions, hepatitis B reactivation, and progressive multifocal leukoencephalopathy, so symptoms like breathing difficulty, severe rash, mouth ulcers, fever, confusion, weakness, or signs of infection should be reported to a doctor immediately.

Label Verification:

Please double-check the physical product label before listing or use, including the product name, strength, active ingredient, manufacturer details, batch number, expiry date, storage instructions, dosage directions, route of administration, and packaging information.

General Information Disclaimer:

The information provided here is for general educational and product-identification purposes only. It should not be considered medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional before starting, stopping, or changing any medication regimen.